CIK 0001678660 · Non-accelerated filer<br>Smaller reporting company
Prelude Therapeutics Inc
Sign in to watch- Ticker
- PRLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811384762
- Phone
- (302) 467-1280
- Business address
- 175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
- Former names
- Prelude Therapeutics Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President, CMO gave up 3,844 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Option exercise President, CMO acquired 9,375 shares (option exercise)
- 4 Shares withheld for taxes President, CMO gave up 3,242 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO bought 1,900 shares at an average $5.15 ($9,790)
- 4 Open-market buy Chief Legal Officer, Corp Sec. bought 2,400 shares at $5.39 ($12,936)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $5.50 ($27,500)
- 4 Open-market buy CEO bought 11,856 shares at $5.63 ($66,749)
- 4 Open-market buy Director bought 869,565 shares at $5.75 ($4,999,999)
- 4 Open-market buy Director bought 869,565 shares at $5.75 ($4,999,999)
- 4 Derivatives Options or other derivatives
Page 4 of 10 · 185 filings